Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:53 AM
Ignite Modification Date:
2025-12-25 @ 4:53 AM
NCT ID:
NCT00414518
Eligibility Criteria:
Inclusion Criteria:
* Acute or recent HIV-1 infection. More information about this criterion can be found in the protocol.
* CD4 count 500 cells/mm3 or greater
* No evidence of prior or current AIDS-defining illness
* No signs or symptoms of HIV infection or AIDS-defining illness that, in the opinion of the investigator, requires ART
* Willing to use acceptable forms of contraception
Exclusion Criteria:
* Prior treatment with any antiretroviral drug for more than 7 days
* Use of certain drugs within 21 days of study entry
* Prior receipt of investigational anti-HIV-1 vaccine
* Ongoing therapy with systemic corticosteroids, chemotherapeutic agents, nephrotoxic systemic agents, immunomodulatory treatments, or investigational agents
* Known allergy/sensitivity to study drugs or their formulations
* Current drug or alcohol use or abuse that, in the opinion of the investigator, may interfere with the study
* Serious medical or psychiatric illness that may interfere with the study
* Hepatitis B infected
* Pregnancy or breastfeeding
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00414518
Study Brief:
Protocol Section:
NCT00414518